# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-021447
Filing Date
2025-06-27
Accepted
2025-06-27 17:25:01
Documents
20
Period of Report
2025-08-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM PRE 14A | mbrx20250623_pre14a.htm iXBRL | PRE 14A | 876461
6 |  | a01.jpg | GRAPHIC | 186317
7 |  | a02.jpg | GRAPHIC | 204220
8 |  | a03.jpg | GRAPHIC | 218367
9 |  | moleculinnewlogoresized.jpg | GRAPHIC | 7783
| Complete submission text file | 0001437749-25-021447.txt |  | 3058694

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | mbrx-20241231.xsd | EX-101.SCH | 4575
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mbrx-20241231_def.xml | EX-101.DEF | 1750
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mbrx-20241231_lab.xml | EX-101.LAB | 1775
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mbrx-20241231_pre.xml | EX-101.PRE | 714
22 | EXTRACTED XBRL INSTANCE DOCUMENT | mbrx20250623_pre14a_htm.xml | XML | 91912

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37758 | Film No.: 251088029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)